A recent study posted to the bioRxiv* preprint server presented topologically engineered fragment crystallizable (Fc)-fusion proteins and antibodies as therapeutic options for diseases like human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback